Amicus Therapeutics (FOLD)

3.70

+0.01 (+0.27%)

Range	3.62 - 3.72
52 week	2.47 - 7.29
Open	3.69
Vol/Avg.	1,261,040

Mkt cap	183.0M
P/E	-
EPS	-1.133
Book/share	1.555

Short ratio	2.00
PEG	-
EPS est.	-0.36

Rare webinar exposes 1 new law that will kill
your wealth in 2013 unless you take action now...

FOLD additional information

Loading ...

Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

Trading Offers • Rare webinar exposes 1 new law that will kill your wealth in 2013 unless you take action now...		Special Offers • Download a free Options Fundamentals Podcast, from The Options Industry Council.

FOLD Profile

•

Exchange

NASDAQ

•

Sector

Healthcare

•

Industry

Biotechnology

•

Held by these Mutual Funds

Fidelity Trend
Bridgeway Ultra-Small Company Market
CREF Stock
iShares Russell Microcap Index
DFA US Small Cap I
Fidelity Large Cap Growth
DFA Tax-Managed US Small Cap
VALIC Company I Small Cap Index
Pacific Select Small-Cap Index
EQ/Small Company Index IA

•

Competitors

Protalix BioTherapeutics
Novo Nordisk A/S
Shire plc

•

Executives

Mr. John F. Crowley
Chairman and Chief Exec. officer

Dr. Pol F. Boudes M.D.
Chief Medical Officer

Dr. David J. Lockhart Ph.D.
Chief Scientific Officer

Mr. Bradley L. Campbell
Chief Bus. Officer

Dr. Robert J. Desnick M.D. .D.

Founder

•

Index Membership

NASDAQ Composite
NASDAQ Biotechnology

•

Employee Count